CAR-T (Chimeric Antigen Receptor T-Cell) therapy represents a revolutionary breakthrough in cancer treatment. This personalized immunotherapy uses genetically modified versions of a patient's own immune cells to fight cancer. The treatment involves extracting T cells from the patient, engineering them in the laboratory to express chimeric antigen receptors (CARs) that can recognize and attack specific cancer cell markers, and then infusing these powerful cells back into the patient.
